Roberto Llarena

403 total citations
23 papers, 305 citations indexed

About

Roberto Llarena is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Roberto Llarena has authored 23 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Roberto Llarena's work include Prostate Cancer Treatment and Research (10 papers), Renal cell carcinoma treatment (8 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Roberto Llarena is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Renal cell carcinoma treatment (8 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Roberto Llarena collaborates with scholars based in Spain, Norway and Canada. Roberto Llarena's co-authors include José I. López, Rafael Pulido, Pedro Bilbao, Alfonso Gómez‐Iturriaga, J.C. Angulo, F. Casquero, Jesús M. Cortés, Rosa Guarch, Peio Errarte and Asier Erramuzpe and has published in prestigious journals such as Scientific Reports, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Roberto Llarena

23 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Llarena Spain	11	191	79	72	66	51	23	305
Vérane Achard Switzerland	10	263 1.4×	87 1.1×	79 1.1×	71 1.1×	52 1.0×	37	359
Robert E. Reiter United States	5	204 1.1×	38 0.5×	62 0.9×	42 0.6×	35 0.7×	14	251
Dominic Leiser Switzerland	11	160 0.8×	45 0.6×	104 1.4×	26 0.4×	50 1.0×	35	366
Charles R. Sikes United States	10	262 1.4×	175 2.2×	122 1.7×	72 1.1×	44 0.9×	12	402
Sasha Beyer United States	10	93 0.5×	66 0.8×	83 1.2×	105 1.6×	33 0.6×	62	323
Shengfu Huang China	11	98 0.5×	86 1.1×	79 1.1×	46 0.7×	27 0.5×	27	344
Melinda E. Stack United States	7	111 0.6×	152 1.9×	78 1.1×	77 1.2×	26 0.5×	13	317
B.V. Offersen Denmark	4	160 0.8×	50 0.6×	89 1.2×	133 2.0×	36 0.7×	15	279
Ruping Zhao China	10	88 0.5×	89 1.1×	121 1.7×	96 1.5×	13 0.3×	26	261
Xiaodan Lin China	14	153 0.8×	92 1.2×	245 3.4×	98 1.5×	20 0.4×	39	473

Countries citing papers authored by Roberto Llarena

Since Specialization

Citations

This map shows the geographic impact of Roberto Llarena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Llarena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Llarena more than expected).

Fields of papers citing papers by Roberto Llarena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Llarena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Llarena. The network helps show where Roberto Llarena may publish in the future.

Co-authorship network of co-authors of Roberto Llarena

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Llarena. A scholar is included among the top collaborators of Roberto Llarena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Llarena. Roberto Llarena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nunes‐Xavier, Caroline E., Tove Øyjord, Gunhild M. Mælandsmo, et al.. (2023). The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma. Scientific Reports. 13(1). 7339–7339. 7 indexed citations

Nunes‐Xavier, Caroline E., Karine Flem‐Karlsen, Gunhild M. Mælandsmo, et al.. (2022). Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer. Frontiers in Oncology. 12. 873516–873516. 15 indexed citations

Nunes‐Xavier, Caroline E., Ingrid Jenny Guldvik, Håkon Ramberg, et al.. (2022). Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer. Pathology - Research and Practice. 241. 154243–154243. 6 indexed citations

Velasco, Guillermo de, Òscar Reig, Francesco Massari, et al.. (2021). Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib. British Journal of Urology. 128(2). 254–261. 2 indexed citations

Nunes‐Xavier, Caroline E., Wanja Kildal, Andreas Kleppe, et al.. (2021). Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer. The Prostate. 81(12). 838–848. 20 indexed citations

Nunes‐Xavier, Caroline E., Tove Øyjord, Gorka Larrinaga, et al.. (2021). 76P B7-H3 immune checkpoint protein expression is associated with immune exhaustion, overall survival and metastasis in clear cell renal cell carcinoma. Annals of Oncology. 32. S1368–S1368. 1 indexed citations

Manini, Claudia, D. Büchser, Roberto Llarena, et al.. (2020). Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. Journal of Personalized Medicine. 10(4). 265–265. 3 indexed citations

Gaafar, Ayman, Caroline E. Nunes‐Xavier, Isabel Guerra, et al.. (2019). Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology. npj Precision Oncology. 3(1). 11–11. 15 indexed citations

Unda, Miguel, et al.. (2019). Seguridad de nivolumab en pacientes con carcinoma de células renales metastásico: experiencia española en urología en la práctica clínica real. Actas Urológicas Españolas. 43(7). 364–370. 4 indexed citations

10.

Beardo, Pastora, et al.. (2019). Safety and outcomes of new generation hormone-therapy in elderly chemotherapy-naive metastatic castration-resistant prostate cancer patients in the real world. Archives of Gerontology and Geriatrics. 82. 179–185. 15 indexed citations

11.

Gómez‐Iturriaga, Alfonso, et al.. (2019). Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18‐F) choline PET‐CT. European Journal of Cancer Care. 28(5). e13093–e13093. 15 indexed citations

12.

Álvarez-Ossorio, J.L., Joaquı́n Carballido, Roberto Llarena, et al.. (2018). Documento nacional de recomendaciones sobre el seguimiento del paciente con carcinoma de células renales. Actas Urológicas Españolas. 42(6). 381–388. 2 indexed citations

13.

López, José I., Peio Errarte, Asier Erramuzpe, et al.. (2016). Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma. Human Pathology. 54. 100–105. 50 indexed citations

14.

Gómez‐Iturriaga, Alfonso, F. Casquero, José I. López, et al.. (2016). Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial. Radiotherapy and Oncology. 119(1). 91–96. 63 indexed citations

15.

Gómez‐Iturriaga, Alfonso, et al.. (2016). Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed Tomography. International Journal of Radiation Oncology*Biology*Physics. 96(2). E250–E250. 1 indexed citations

16.

Büchser, D., Alfonso Gómez‐Iturriaga, F. Casquero, et al.. (2016). Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy. Journal of Contemporary Brachytherapy. 6(6). 477–483. 11 indexed citations

17.

Gómez‐Iturriaga, Alfonso, F. Casquero, Roberto Llarena, et al.. (2013). Impact of magnetic resonance imaging in the local staging, risk group classification and treatment of prostate cancer patients with combination of high dose rate brachytherapy and external beam radiotherapy. Reports of Practical Oncology & Radiotherapy. 18. S321–S322. 1 indexed citations

18.

Moróte, Juan, Ángel Borque‐Fernando, Elisabet Ars, et al.. (2010). Improved Prediction of Biochemical Recurrence After Radical Prostatectomy by Genetic Polymorphisms. The Journal of Urology. 184(2). 506–511. 29 indexed citations

19.

Pertusa, C, et al.. (1992). In vitro Lithotripsy with the Alexandrite Laser. European Urology. 22(1). 62–63. 5 indexed citations

20.

Pertusa, C, et al.. (1991). Lithotripsy with the Alexandrite Laser:Our Initial 100 Clinical Cases(1). European Urology. 20(4). 269–271. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact